Budesonide Treatment for Lymphocytic Colitis

Last updated: March 29, 2010
Sponsor: Technische Universität Dresden
Overall Status: Completed

Phase

3

Condition

Inflammatory Bowel Disease

Crohn's Disease

Treatment

N/A

Clinical Study ID

NCT00180050
BLYCK
  • Ages 18-80
  • All Genders

Study Summary

The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • lymphocytic colitis

  • diarrhea

  • effective contraception

  • written informed consent

Exclusion

Exclusion Criteria:

  • other forms if IBD

  • celiac disease

  • infectious colitis

  • history of colonic surgery

  • use of budesonide, 5-ASA, steroids within th previous 4 weeks

  • pregnancy, lactation

Study Design

Total Participants: 40
Study Start date:
January 01, 2002
Estimated Completion Date:
August 31, 2007

Study Description

The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis

Connect with a study center

  • Medical Department I, Technical University Hospital

    Dresden, 01307
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.